Compass Therapeutics (CMPX) Capital Expenditures Growth (1y) (2020 - 2026)
Compass Therapeutics (CMPX) Capital Expenditures Growth (1y) (2020 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Capex Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
- |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
- |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
- |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
227.76% |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
- |
| 10 |
Compass Therapeutics |
376.53 Mn |
181.84 Mn |
- |
355.56% |
| Date | Value |
|---|
| Mar 31, 2026 |
355.56% |
| Sep 30, 2025 |
-84.09% |
| Sep 30, 2024 |
340.00% |
| Dec 31, 2023 |
-83.33% |
| Sep 30, 2023 |
-62.96% |
| Jun 30, 2023 |
117.46% |
| Dec 31, 2022 |
-93.05% |
| Sep 30, 2022 |
-92.64% |
| Jun 30, 2022 |
-123.95% |
| Mar 31, 2022 |
20.50% |
| Sep 30, 2021 |
1,495.65% |
| Jun 20, 2021 |
1,543.75% |
| Mar 31, 2021 |
1,241.67% |
| Sep 30, 2020 |
-91.81% |
| Jun 30, 2020 |
-93.70% |
